76 related articles for article (PubMed ID: 22379153)
1. Autoimmune Pulmonary Alveolar Proteinosis Complicated by Myelodysplastic Syndrome.
Shimaya M; Inagaki Y; Arai T; Kawakami M; Takeuchi N; Sumikawa H; Shimizu S; Takimoto T; Inoue Y
Intern Med; 2024 May; 63(10):1451-1457. PubMed ID: 37839886
[TBL] [Abstract][Full Text] [Related]
2. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.
Sakagami T; Beck D; Uchida K; Suzuki T; Carey BC; Nakata K; Keller G; Wood RE; Wert SE; Ikegami M; Whitsett JA; Luisetti M; Davies S; Krischer JP; Brody A; Ryckman F; Trapnell BC
Am J Respir Crit Care Med; 2010 Jul; 182(1):49-61. PubMed ID: 20224064
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary alveolar proteinosis, a primary immunodeficiency of impaired GM-CSF stimulation of macrophages.
Trapnell BC; Carey BC; Uchida K; Suzuki T
Curr Opin Immunol; 2009 Oct; 21(5):514-21. PubMed ID: 19796925
[TBL] [Abstract][Full Text] [Related]
4. Cytokine profiles associated with disease severity and prognosis of autoimmune pulmonary alveolar proteinosis.
Akasaka K; Amano M; Nakamura T; Nishizawa T; Yamakawa H; Sato S; Aoki A; Shima K; Matsushima H; Takada T
Respir Investig; 2024 Jul; 62(4):610-616. PubMed ID: 38705133
[TBL] [Abstract][Full Text] [Related]
5. Opportunistic infections in autoimmune pulmonary alveolar proteinosis: opportunity to better understand the role of GM-CSF in the innate immune response.
O'Callaghan M; Penugonda M; McCarthy C
Thorax; 2023 Dec; 79(1):7-8. PubMed ID: 37758455
[No Abstract] [Full Text] [Related]
6. Will inhalational GM-CSF replace whole lung lavage as a treatment for autoimmune pulmonary alveolar proteinosis? Many pole positions, not yet the final winner.
Bonella F; Manali ED; Papiris SA
Eur Respir J; 2024 Jan; 63(1):. PubMed ID: 38176702
[No Abstract] [Full Text] [Related]
7. Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis.
Sakaue S; Yamaguchi E; Inoue Y; Takahashi M; Hirata J; Suzuki K; Ito S; Arai T; Hirose M; Tanino Y; Nikaido T; Ichiwata T; Ohkouchi S; Hirano T; Takada T; Miyawaki S; Dofuku S; Maeda Y; Nii T; Kishikawa T; Ogawa K; Masuda T; Yamamoto K; Sonehara K; Tazawa R; Morimoto K; Takaki M; Konno S; Suzuki M; Tomii K; Nakagawa A; Handa T; Tanizawa K; Ishii H; Ishida M; Kato T; Takeda N; Yokomura K; Matsui T; Watanabe M; Inoue H; Imaizumi K; Goto Y; Kida H; Fujisawa T; Suda T; Yamada T; Satake Y; Ibata H; Hizawa N; Mochizuki H; Kumanogoh A; Matsuda F; Nakata K; Hirota T; Tamari M; Okada Y
Nat Commun; 2021 Feb; 12(1):1032. PubMed ID: 33589587
[TBL] [Abstract][Full Text] [Related]
8. Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.
Mabo A; Borie R; Wemeau-Stervinou L; Uzunhan Y; Gomez E; Prevot G; Reynaud-Gaubert M; Traclet J; Bergot E; Cadranel J; Marchand-Adam S; Bergeron A; Blanchard E; Bondue B; Bonniaud P; Bourdin A; Burgel PR; Hirschi S; Marquette CH; Quétant S; Nunes H; Chenivesse C; Crestani B; Guirriec Y; Monnier D; Ménard C; Tattevin P; Cottin V; Luque Paz D; Jouneau S;
Thorax; 2023 Dec; 79(1):68-74. PubMed ID: 37758458
[TBL] [Abstract][Full Text] [Related]
9. Advancements in pulmonary alveolar proteinosis treatment: A journey from discovery to GM-CSF inhalation therapy.
Sakagami T
Respir Investig; 2024 May; 62(3):375-376. PubMed ID: 38437758
[No Abstract] [Full Text] [Related]
10. The ouroboros of autoimmunity.
Casanova JL; Peel J; Donadieu J; Neehus AL; Puel A; Bastard P
Nat Immunol; 2024 May; 25(5):743-754. PubMed ID: 38698239
[TBL] [Abstract][Full Text] [Related]
11. Duration of benefit in patients with autoimmune pulmonary alveolar proteinosis after inhaled granulocyte-macrophage colony-stimulating factor therapy.
Tazawa R; Inoue Y; Arai T; Takada T; Kasahara Y; Hojo M; Ohkouchi S; Tsuchihashi Y; Yokoba M; Eda R; Nakayama H; Ishii H; Nei T; Morimoto K; Nasuhara Y; Ebina M; Akira M; Ichiwata T; Tatsumi K; Yamaguchi E; Nakata K
Chest; 2014 Apr; 145(4):729-737. PubMed ID: 24158247
[TBL] [Abstract][Full Text] [Related]
12. Autoimmune pulmonary alveolar proteinosis: treatment options in year 2013.
Leth S; Bendstrup E; Vestergaard H; Hilberg O
Respirology; 2013 Jan; 18(1):82-91. PubMed ID: 23036113
[TBL] [Abstract][Full Text] [Related]
13. Bilateral peripheral infiltrates refractory to immunosuppressants were diagnosed as autoimmune pulmonary alveolar proteinosis and improved by inhalation of granulocyte/macrophage-colony stimulating factor.
Satoh H; Tazawa R; Sakakibara T; Ohkouchi S; Ebina M; Miki M; Nakata K; Nukiwa T
Intern Med; 2012; 51(13):1737-42. PubMed ID: 22790136
[TBL] [Abstract][Full Text] [Related]
14. Outcome of corticosteroid administration in autoimmune pulmonary alveolar proteinosis: a retrospective cohort study.
Akasaka K; Tanaka T; Kitamura N; Ohkouchi S; Tazawa R; Takada T; Ichiwata T; Yamaguchi E; Hirose M; Arai T; Nakano K; Nei T; Ishii H; Handa T; Inoue Y; Nakata K
BMC Pulm Med; 2015 Aug; 15():88. PubMed ID: 26264717
[TBL] [Abstract][Full Text] [Related]
15. Dual Role of GM-CSF as a Pro-Inflammatory and a Regulatory Cytokine: Implications for Immune Therapy.
Bhattacharya P; Budnick I; Singh M; Thiruppathi M; Alharshawi K; Elshabrawy H; Holterman MJ; Prabhakar BS
J Interferon Cytokine Res; 2015 Aug; 35(8):585-99. PubMed ID: 25803788
[TBL] [Abstract][Full Text] [Related]
16. ABL tyrosine kinase inhibitor-induced pulmonary alveolar proteinosis in chronic myeloid leukemia.
Yoshimura M; Kojima K; Tomimasu R; Fukushima N; Hayashi S; Sueoka E; Kimura S
Int J Hematol; 2014 Dec; 100(6):611-4. PubMed ID: 25212679
[TBL] [Abstract][Full Text] [Related]
17. Reduced GM-CSF autoantibody in improved lung of autoimmune pulmonary alveolar proteinosis.
Ohashi K; Sato A; Takada T; Arai T; Kasahara Y; Hojo M; Nei T; Nakayama H; Motoi N; Urano S; Eda R; Yokoba M; Tsuchihashi Y; Nasuhara Y; Ishii H; Ebina M; Yamaguchi E; Inoue Y; Nakata K; Tazawa R
Eur Respir J; 2012 Mar; 39(3):777-80. PubMed ID: 22379153
[No Abstract] [Full Text] [Related]
18. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
[TBL] [Abstract][Full Text] [Related]
19. Granulocyte-macrophage colony-stimulating factor and lung immunity in pulmonary alveolar proteinosis.
Tazawa R; Hamano E; Arai T; Ohta H; Ishimoto O; Uchida K; Watanabe M; Saito J; Takeshita M; Hirabayashi Y; Ishige I; Eishi Y; Hagiwara K; Ebina M; Inoue Y; Nakata K; Nukiwa T
Am J Respir Crit Care Med; 2005 May; 171(10):1142-9. PubMed ID: 15735059
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
